Summary

The global Glabridin market was valued at US$ 37.74 million in 2024 and is anticipated to reach US$ 59.43 million by 2031, witnessing a CAGR of 6.84% during the forecast period 2025-2031.
North American market for Glabridin is estimated to increase from $5.96 million in 2024 to reach $9.20 million by 2031, at a CAGR of 6.35% during the forecast period of 2024 through 2031.
Asia-Pacific market for Glabridin is estimated to increase from $21.09 million in 2024 to reach $33.86 million by 2031, at a CAGR of 7.17% during the forecast period of 2024 through 2031.

The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
This report aims to provide a comprehensive presentation of the global market for Glabridin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glabridin.

The Glabridin market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glabridin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glabridin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation
By Company
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss

Segment by Type
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)

Segment by Application
Creams and Lotions
Masks
Sunscreen Products
Others

Consumption by Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe

Latin America
Mexico
Brazil

Middle East & Africa
GCC Countries
Turkey
Africa

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glabridin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glabridin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Glabridin Market Overview 1
1.1 Product Definition 1
1.2 Glabridin by Type 1
1.3 Glabridin by Application 3
1.3.1 Global Glabridin Market Value by Application (2025-2031) 3
1.3.2 Creams and Lotions 5
1.3.3 Masks 6
1.3.4 Sunscreen Products 7
1.3.5 Others 8
1.4 Global Glabridin Market Size Estimates and Forecasts 8
1.4.1 Global Glabridin Revenue 2020-2031 8
1.4.2 Global Glabridin Sales 2020-2031 10
1.4.3 Global Glabridin Market Average Price (2020-2031) 11
1.5 Assumptions and Limitations 11
2 Glabridin Market Competition by Manufacturers 14
2.1 Global Glabridin Sales Market Share by Manufacturers (2020-2025) 14
2.2 Global Glabridin Revenue Market Share by Manufacturers (2020-2025) 17
2.3 Global Glabridin Average Price by Manufacturers (2020-2025) 20
2.4 Global Key Players of Glabridin, Industry Ranking, 2023 VS 2024 VS 2025 20
2.5 Global Key Manufacturers of Glabridin, Manufacturing Sites & Headquarters 21
2.6 Global Key Manufacturers of Glabridin, Product Type & Application 22
2.7 Global Key Manufacturers of Glabridin, Date of Establishment in This Industry 23
2.8 Global Glabridin Market Competitive Situation and Trends 23
2.8.1 Global Glabridin Market Concentration Rate 23
2.8.2 The Global 3 and 6 Largest Glabridin Players Market Share by Revenue 25
2.8.3 Global Glabridin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 26
3 Global Glabridin Market Scenario by Region 28
3.1 Global Glabridin Market Size by Region: 2020 Versus 2024 Versus 2031 28
3.2 Global Glabridin Sales by Region: 2020-2031 29
3.2.1 Global Glabridin Sales by Region: 2020-2025 29
3.2.2 Global Glabridin Sales by Region: 2026-2031 30
3.3 Global Glabridin Revenue by Region: 2020-2031 31
3.3.1 Global Glabridin Revenue by Region: 2020-2025 31
3.3.2 Global Glabridin Revenue by Region: 2026-2031 31
3.4 North America Glabridin Market Facts & Figures by Country 32
3.4.1 North America Glabridin Market Size by Country: 2020 VS 2024 VS 2031 32
3.4.2 North America Glabridin Sales by Country (2020-2031) 32
3.4.3 North America Glabridin Revenue by Country (2020-2031) 33
3.4.4 United States 35
3.4.5 Canada 35
3.5 Europe Glabridin Market Facts & Figures by Country 36
3.5.1 Europe Glabridin Market Size by Country: 2020 VS 2024 VS 2031 36
3.5.2 Europe Glabridin Sales by Country (2020-2031) 36
3.5.3 Europe Glabridin Revenue by Country (2020-2031) 37
3.5.4 Germany 39
3.5.5 France 39
3.5.6 U.K. 40
3.5.7 Italy 41
3.5.8 Spain 41
3.6 Asia Pacific Glabridin Market Facts & Figures by Region 42
3.6.1 Asia Pacific Glabridin Market Size by Region: 2020 VS 2024 VS 2031 42
3.6.2 Asia Pacific Glabridin Sales by Region (2020-2031) 42
3.6.3 Asia Pacific Glabridin Revenue by Region (2020-2031) 43
3.6.4 China 45
3.6.5 Japan 46
3.6.6 South Korea 47
3.6.7 India 47
3.6.8 Southeast Asia 48
3.6.9 Australia 49
3.7 Latin America Glabridin Market Facts & Figures by Country 49
3.7.1 Latin America Glabridin Market Size by Country: 2020 VS 2024 VS 2031 49
3.7.2 Latin America Glabridin Sales by Country (2020-2031) 50
3.7.3 Latin America Glabridin Revenue by Country 51
3.7.4 Mexico 52
3.7.5 Brazil 53
3.8 Middle East and Africa Glabridin Market Facts & Figures by Region 53
3.8.1 Middle East and Africa Glabridin Market Size by Region: 2020 VS 2024 VS 2031 53
3.8.2 Middle East and Africa Glabridin Sales by Region (2020-2031) 54
3.8.3 Middle East and Africa Glabridin Revenue by Region 55
3.8.4 GCC Countries 57
3.8.5 Turkey 57
3.8.6 Africa 58
4 Segment by Type 59
4.1 Global Glabridin Sales by Type (2020-2031) 59
4.1.1 Global Glabridin Sales by Type (2020-2025) 59
4.1.2 Global Glabridin Sales by Type (2026-2031) 59
4.1.3 Global Glabridin Sales Market Share by Type (2020-2031) 59
4.2 Global Glabridin Revenue by Type (2020-2031) 61
4.2.1 Global Glabridin Revenue by Type (2020-2025) 61
4.2.2 Global Glabridin Revenue by Type (2026-2031) 61
4.2.3 Global Glabridin Revenue Market Share by Type (2020-2031) 61
4.3 Global Glabridin Price by Type (2020-2031) 63
5 Segment by Application 64
5.1 Global Glabridin Sales by Application (2020-2031) 64
5.1.1 Global Glabridin Sales by Application (2020-2025) 64
5.1.2 Global Glabridin Sales by Application (2026-2031) 64
5.1.3 Global Glabridin Sales Market Share by Application (2020-2031) 64
5.2 Global Glabridin Revenue by Application (2020-2031) 66
5.2.1 Global Glabridin Revenue by Application (2020-2025) 66
5.2.2 Global Glabridin Revenue by Application (2026-2031) 66
5.2.3 Global Glabridin Revenue Market Share by Application (2020-2031) 66
5.3 Global Glabridin Price by Application (2020-2031) 67
6 Key Companies Profiled 69
6.1 Sabinsa 69
6.1.1 Sabinsa Company Information 69
6.1.2 Sabinsa Description and Business Overview 69
6.1.3 Sabinsa Glabridin Sales, Revenue and Gross Margin (2020-2025) 70
6.1.4 Sabinsa Glabridin Product Portfolio 70
6.1.5 Sabinsa Recent Developments/Updates 71
6.2 Mafco 71
6.2.1 Mafco Company Information 71
6.2.2 Mafco Description and Business Overview 72
6.2.3 Mafco Glabridin Sales, Revenue and Gross Margin (2020-2025) 72
6.2.4 Mafco Glabridin Product Portfolio 72
6.3 Maruzen Pharmaceuticals 73
6.3.1 Maruzen Pharmaceuticals Company Information 73
6.3.2 Maruzen Pharmaceuticals Description and Business Overview 73
6.3.3 Maruzen Pharmaceuticals Glabridin Sales, Revenue and Gross Margin (2020-2025) 74
6.3.4 Maruzen Pharmaceuticals Glabridin Product Portfolio 74
6.4 Hyundai Bioland 74
6.4.1 Hyundai Bioland Company Information 74
6.4.2 Hyundai Bioland Description and Business Overview 75
6.4.3 Hyundai Bioland Glabridin Sales, Revenue and Gross Margin (2020-2025) 75
6.4.4 Hyundai Bioland Glabridin Product Portfolio 76
6.5 Shanghai OLI 76
6.5.1 Shanghai OLI Company Information 76
6.5.2 Shanghai OLI Description and Business Overview 77
6.5.3 Shanghai OLI Glabridin Sales, Revenue and Gross Margin (2020-2025) 78
6.5.4 Shanghai OLI Glabridin Product Portfolio 78
6.6 Lepro Herbals 78
6.6.1 Lepro Herbals Company Information 78
6.6.2 Lepro Herbals Description and Business Overview 79
6.6.3 Lepro Herbals Glabridin Sales, Revenue and Gross Margin (2020-2025) 79
6.6.4 Lepro Herbals Glabridin Product Portfolio 80
6.7 Gansu Fanzhi Pharmaceutical 80
6.7.1 Gansu Fanzhi Pharmaceutical Company Information 80
6.7.2 Gansu Fanzhi Pharmaceutical Description and Business Overview 81
6.7.3 Gansu Fanzhi Pharmaceutical Glabridin Sales, Revenue and Gross Margin (2020-2025) 81
6.7.4 Gansu Fanzhi Pharmaceutical Glabridin Product Portfolio 82
6.8 Qinghai Lake Pharmaceutical 83
6.8.1 Qinghai Lake Pharmaceutical Company Information 83
6.8.2 Qinghai Lake Pharmaceutical Description and Business Overview 83
6.8.3 Qinghai Lake Pharmaceutical Glabridin Sales, Revenue and Gross Margin (2020-2025) 84
6.8.4 Qinghai Lake Pharmaceutical Glabridin Product Portfolio 84
6.9 Hangzhou Lingeba Technology 85
6.9.1 Hangzhou Lingeba Technology Company Information 85
6.9.2 Hangzhou Lingeba Technology Description and Business Overview 85
6.9.3 Hangzhou Lingeba Technology Glabridin Sales, Revenue and Gross Margin (2020-2025) 86
6.9.4 Hangzhou Lingeba Technology Glabridin Product Portfolio 86
6.10 Shaanxi Huatai Bio 87
6.10.1 Shaanxi Huatai Bio Company Information 87
6.10.2 Shaanxi Huatai Bio Description and Business Overview 88
6.10.3 Shaanxi Huatai Bio Glabridin Sales, Revenue and Gross Margin (2020-2025) 88
6.10.4 Shaanxi Huatai Bio Glabridin Product Portfolio 89
6.11 Huzhou Ouli Biological Technology 89
6.11.1 Huzhou Ouli Biological Technology Company Information 89
6.11.2 Huzhou Ouli Biological Technology Description and Business Overview 90
6.11.3 Huzhou Ouli Biological Technology Glabridin Sales, Revenue and Gross Margin (2020-2025) 90
6.11.4 Huzhou Ouli Biological Technology Glabridin Product Portfolio 91
6.12 Plamed Green Science Group 91
6.12.1 Plamed Green Science Group Company Information 91
6.12.2 Plamed Green Science Group Description and Business Overview 92
6.12.3 Plamed Green Science Group Glabridin Sales, Revenue and Gross Margin (2020-2025) 93
6.12.4 Plamed Green Science Group Glabridin Product Portfolio 94
6.13 Xi'an Zhongying 95
6.13.1 Xi'an Zhongying Company Information 95
6.13.2 Xi'an Zhongying Description and Business Overview 95
6.13.3 Xi'an Zhongying Glabridin Sales, Revenue and Gross Margin (2020-2025) 96
6.13.4 Xi'an Zhongying Glabridin Product Portfolio 96
6.14 Huaian Brothers Biotechnology 97
6.14.1 Huaian Brothers Biotechnology Company Information 97
6.14.2 Huaian Brothers Biotechnology Description and Business Overview 97
6.14.3 Huaian Brothers Biotechnology Glabridin Sales, Revenue and Gross Margin (2020-2025) 98
6.14.4 Huaian Brothers Biotechnology Glabridin Product Portfolio 98
6.15 Alchem International 99
6.15.1 Alchem International Company Information 99
6.15.2 Alchem International Description and Business Overview 99
6.15.3 Alchem International Glabridin Sales, Revenue and Gross Margin (2020-2025) 100
6.15.4 Alchem International Glabridin Product Portfolio 100
6.16 Ambe Phytoextracts 101
6.16.1 Ambe Phytoextracts Company Information 101
6.16.2 Ambe Phytoextracts Description and Business Overview 101
6.16.3 Ambe Phytoextracts Glabridin Sales, Revenue and Gross Margin (2020-2025) 102
6.16.4 Ambe Phytoextracts Glabridin Product Portfolio 102
6.17 Sunpure Extracts 103
6.17.1 Sunpure Extracts Company Information 103
6.17.2 Sunpure Extracts Description and Business Overview 104
6.17.3 Sunpure Extracts Glabridin Sales, Revenue and Gross Margin (2020-2025) 104
6.17.4 Sunpure Extracts Glabridin Product Portfolio 105
6.18 Novel Nutrientss 105
6.18.1 Novel Nutrientss Company Information 105
6.18.2 Novel Nutrientss Description and Business Overview 106
6.18.3 Novel Nutrientss Glabridin Sales, Revenue and Gross Margin (2020-2025) 106
6.18.4 Novel Nutrientss Glabridin Product Portfolio 106
7 Industry Chain and Sales Channels Analysis 108
7.1 Glabridin Industry Chain Analysis 108
7.2 Glabridin Raw Material Supply Analysis 108
7.2.1 Key Raw Materials 108
7.2.2 Raw Materials Key Suppliers 109
7.3 Glabridin Production Mode & Process Analysis 110
7.4 Glabridin Sales and Marketing 111
7.4.1 Glabridin Sales Channels 111
7.4.2 Glabridin Distributors 111
7.5 Glabridin Customer Analysis 112
8 Glabridin Market Dynamics 113
8.1 Glabridin Industry Trends 113
8.2 Glabridin Market Drivers 114
8.3 Glabridin Market Challenges 115
8.4 Glabridin Market Restraints 116
9 Research Findings and Conclusion 117
10 Methodology and Data Source 118
10.1 Methodology/Research Approach 118
10.1.1 Research Programs/Design 118
10.1.2 Market Size Estimation 119
10.1.3 Market Breakdown and Data Triangulation 120
10.2 Data Source 121
10.2.1 Secondary Sources 121
10.2.2 Primary Sources 122
10.3 Author List 124
10.4 Disclaimer 124